Myers, R
The problem was the side effects associated, particularly with GLP-1, are what we call peak to trough: so the difference between the highest amount of drug and the lowest and then going back up again to the highest caused by this twice-a-day dosingwhich you can imagine someone bouncing around maybe two to three times, the drug at peak, then trough, causes a lot of GI distress
Higuchi N, Kato M, Tanaka M, Miyazaki M, Takao S, Kohjima M, Kotoh K, Enjoji M, Nakamuta M, Takayanagi R (2011) Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease
If you have chronic kidney disease, consult your healthcare provider before significantly increasing your protein intake
A conservative approach using 0.25 mg daily for the first two weeks allows assessment of individual response before considering increases
When prescribed and monitored by qualified medical professionals, CJC-1295 is generally well tolerated